Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation

To identify a new drug candidate for treating endometriosis which has fewer side effects, a new polymeric nanoparticle gene delivery system consisting of polyethylenimine-grafted chitosan oligosaccharide (CSO-PEI) with hyaluronic acid (HA) and small interfering RNA (siRNA) was designed. There was no...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Nanomedicine
Päätekijät: Zhao, Meng-Dan, Cheng, Jin-Lin, Yan, Jing-Jing, Chen, Feng-Ying, Sheng, Jian-Zhong, Sun, Dong-Li, Chen, Jian, Miao, Jing, Zhang, Run-Ju, Zheng, Cai-Hong, Huang, He-Feng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2016
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4821386/
https://ncbi.nlm.nih.gov/pubmed/27099493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S99692
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia